Abstract
Objectives: The need for new antimalarials drugs and drug targets is pertinent due to the emergence of drug resistant strains of the parasites. Improper target selection has resulted in therapeutic failure. The genomic/post genomic era has made possible the deciphering of the 3D crystal structures of proteins and DNA which are drug targets and are deposited in the protein data bank.
 Methods: Novel antimalarial targets obtained from evolutionary conserved short sequence motifs are utilised and are essential in transcription processes in the parasite. The motifs TGCATGCA, GTGCAC and GTGCGTGC were curated from experimental work, validated and analysed via phylogenomics genomics and comparative genomics. PlasmoDB blastn was applied to determine their similarity in Plasmodium vivax, knowlesi, Ovale and yoeli. The complete genome of Plasmodium falciparum vivax, knowlesi, Ovale and yoeli was downloaded from the plasmoDB and their positions determined.
 Results: The targets are essential, conserved in rodent and mammalian species via phylogenomics with percentage identity and similarity greater than 80%, have no similar genes in the same genome and also found to be selective in the parasites vis-à-vis the Homo sapiens via comparative genomics with 0% identity and similarity in the human genome.
 Conclusion: The targets reveal at the molecular and biochemical level, the vulnerable regions in the parasite while safe in human hence their choices in subsequent rationale drug discovery and design protocols.
 Peer Review History: 
 Received: 18 July 2020; Revised: 1 October; Accepted: 12 October, Available online: 15 November 2020
 UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency.
 Received file 
 
 Average Peer review marks at initial stage: 5.5/10
 Average Peer review marks at publication stage: 7.0/10
 Reviewer(s) detail:
 Dr. Tamer ELHABIBI, ERU University, Egypt, tamer_elhabibi@yahoo.com
 Dr. Soroush Sardari, Biotech Pasteur Institute of Iran, Tehran, Iran, ssardari@hotmail.com
 Comments of reviewer(s): 
 
 Similar Articles:
 IN SILICO LIGAND-BASED 2D PHARMACOPHORE GENERATION FOR H+/K+ ATPASE INHIBITORS
Highlights
In silico antimalarial target selection conserved in four Plasmodium species
The motifs as follows: TGCATGCA GTGCAC GTGCGTG Datasets The entire genome sequence of the Plasmodium falciparum was downloaded via the file transfer protocol ftp from the database of the National Centre for Biotechnology Information (NCBI) site
The process of searching and obtaining clearly defined targets was done via extensive literature search in which the motifs were selected, based on their various roles in the biochemical and metabolic processes within the Plasmodium parasites[15]
Summary
In silico antimalarial target selection conserved in four Plasmodium species. Focus is placed on the generation of an inventory of potential targets for therapeutics based on human and pathogen genome sequence studies to replenish the depleted pipeline. The motifs as follows: TGCATGCA GTGCAC GTGCGTG Datasets The entire genome sequence of the Plasmodium falciparum was downloaded via the file transfer protocol ftp from the database of the National Centre for Biotechnology Information (NCBI) (ftp) site.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
